Family Care Hospitals Ltd
Incorporated in 1994, Family Care Hospitals Ltd is in the business of providing Healthcare Services.[1]
- Market Cap ₹ 9.72 Cr.
- Current Price ₹ 1.80
- High / Low ₹ 4.08 / 1.61
- Stock P/E
- Book Value ₹ 1.53
- Dividend Yield 0.00 %
- ROCE -23.2 %
- ROE -35.4 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.17 times its book value
- Company has a good return on equity (ROE) track record: 3 Years ROE 39.4%
Cons
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -4.18%
- The company has delivered a poor sales growth of -64.1% over past five years.
- Promoter holding is low: 13.3%
- Contingent liabilities of Rs.5.09 Cr.
- Promoters have pledged 86.1% of their holding.
- Company has high debtors of 1,755 days.
- Working capital days have increased from 3,504 days to 9,855 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.07 | 1.07 | 1.80 | 5.19 | 14.19 | 13.25 | 35.36 | 42.07 | 42.04 | 40.01 | 7.90 | 0.21 | 0.24 | |
| Sales growth | +600.00% | +1,428.57% | +68.22% | +188.33% | +173.41% | -6.62% | +166.87% | +18.98% | -0.07% | -4.83% | -80.25% | -97.34% | +166.67% |
| 0.24 | 0.86 | 1.54 | 3.84 | 12.73 | 10.98 | 27.18 | 33.37 | 33.59 | 33.12 | -20.80 | 3.22 | -0.73 | |
| Operating Profit | -0.17 | 0.21 | 0.26 | 1.35 | 1.46 | 2.27 | 8.18 | 8.70 | 8.45 | 6.89 | 28.70 | -3.01 | 0.97 |
| OPM % | -242.86% | 19.63% | 14.44% | 26.01% | 10.29% | 17.13% | 23.13% | 20.68% | 20.10% | 17.22% | 363.29% | -1,433.33% | 404.17% |
| -24.63 | 0.20 | 0.19 | 0.24 | 0.04 | -0.12 | -0.28 | 0.30 | 0.98 | 3.19 | -71.71 | -4.39 | -4.13 | |
| Interest | 0.00 | 0.01 | 0.01 | 0.12 | 0.51 | 0.84 | 0.83 | 0.50 | 0.60 | 0.53 | 0.33 | 0.40 | 0.56 |
| Depreciation | 0.03 | 0.38 | 0.25 | 0.39 | 0.94 | 1.28 | 1.42 | 1.44 | 1.41 | 1.42 | 1.13 | 0.88 | 0.82 |
| Profit before tax | -24.83 | 0.02 | 0.19 | 1.08 | 0.05 | 0.03 | 5.65 | 7.06 | 7.42 | 8.13 | -44.47 | -8.68 | -4.54 |
| Tax % | 0.00% | 0.00% | 21.05% | 20.37% | 60.00% | 33.33% | 27.96% | 26.35% | 29.11% | -54.24% | -0.72% | 0.00% | |
| -24.83 | 0.02 | 0.16 | 0.86 | 0.02 | 0.03 | 4.07 | 5.20 | 5.26 | 12.55 | -44.15 | -8.68 | -4.54 | |
| EPS in Rs | -7.09 | 0.01 | 0.05 | 0.25 | 0.01 | 0.01 | 1.16 | 1.49 | 0.97 | 2.32 | -8.17 | -1.61 | -0.85 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.17% | 5.13% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -15% |
| 5 Years: | -64% |
| 3 Years: | -83% |
| TTM: | 167% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 90% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -17% |
| 5 Years: | -37% |
| 3 Years: | -43% |
| 1 Year: | -55% |
| Return on Equity | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 35% |
| 3 Years: | 39% |
| Last Year: | -35% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 54.01 | 54.01 | 54.01 | 54.01 | 54.01 |
| Reserves | -28.18 | -28.16 | -28.01 | -27.15 | -27.13 | -27.09 | -23.03 | -17.86 | -8.21 | 4.36 | -40.56 | -44.56 | -45.72 |
| 0.56 | 0.56 | 0.10 | 0.28 | 5.60 | 9.53 | 5.50 | 4.26 | 4.32 | 3.65 | 3.39 | 5.17 | 5.74 | |
| 0.04 | 0.08 | 1.31 | 4.66 | 3.22 | 2.59 | 5.81 | 21.34 | 24.46 | 7.94 | 29.25 | 28.46 | 28.52 | |
| Total Liabilities | 4.52 | 4.58 | 5.50 | 9.89 | 13.79 | 17.13 | 20.38 | 39.84 | 74.58 | 69.96 | 46.09 | 43.08 | 42.55 |
| 1.74 | 1.84 | 2.44 | 7.24 | 8.61 | 9.52 | 8.01 | 6.82 | 6.93 | 5.95 | 4.00 | 2.90 | 2.50 | |
| CWIP | 0.00 | 0.00 | 0.60 | 0.86 | 0.06 | 0.04 | 0.09 | 0.09 | 0.09 | 0.06 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 2.78 | 2.74 | 2.46 | 1.79 | 5.12 | 7.57 | 12.28 | 32.93 | 67.56 | 63.95 | 42.09 | 40.18 | 40.05 | |
| Total Assets | 4.52 | 4.58 | 5.50 | 9.89 | 13.79 | 17.13 | 20.38 | 39.84 | 74.58 | 69.96 | 46.09 | 43.08 | 42.55 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.07 | 0.34 | 0.46 | 3.04 | -4.12 | -1.29 | 3.90 | 1.68 | -5.26 | -0.37 | -17.32 | -6.04 | |
| -1.77 | -0.48 | -1.45 | -5.45 | -1.51 | -2.32 | -0.26 | -0.25 | -1.54 | -0.41 | 0.65 | 0.00 | |
| 4.52 | 0.00 | 0.78 | 0.26 | 5.86 | 4.75 | -4.82 | -1.67 | 25.87 | -1.04 | -0.55 | 6.07 | |
| Net Cash Flow | 2.68 | -0.14 | -0.21 | -2.14 | 0.23 | 1.14 | -1.17 | -0.23 | 19.08 | -1.83 | -17.22 | 0.03 |
| Free Cash Flow | -1.84 | -0.14 | -0.99 | -2.41 | -5.63 | -3.61 | 3.64 | 1.42 | -6.80 | -0.78 | -16.67 | -6.04 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 41% | 162% | 192% | 241% | -280% | -56% | 67% | 41% | -39% | -74% | -60% | 201% |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 64.56 | 112.67 | 93.21 | 186.19 | 251.96 | 310.35 | 93.33 | 1,755.48 |
| Inventory Days | 149.08 | 29.44 | 3.74 | 6.18 | 16.46 | 138,809.50 | ||||||
| Days Payable | 976.76 | 211.94 | 382.44 | 386.99 | 112.66 | 86,286.00 | ||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 64.56 | -715.01 | -89.29 | -192.52 | -128.86 | 214.15 | 93.33 | 54,278.98 |
| Working Capital Days | -2,920.00 | -160.33 | -271.72 | -311.55 | -145.85 | -16.25 | 54.71 | 99.86 | 149.42 | 254.98 | 402.42 | 9,855.00 |
| ROCE % | -3.97% | 0.67% | 4.60% | 25.48% | 7.09% | 8.04% | 46.58% | 45.78% | 23.40% | 15.44% | 77.91% | -23.20% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees employees |
|
||||||||||
| Number of Operational Hospitals hospitals |
|||||||||||
| Cumulative Patients/Patrons Served patrons |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Resignation of Director
- Independent Director Dhananjay Parikh resigns effective Nov 14, 2026 due professional commitments.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Enclosed copies of Newspaper Advisement published in English and reginal langue on November 15, 2026 with respect to Unaudited Financial Result for Quarter ended September …
-
Result - Unaudited Financial Result For Quarter And Year Ended September 30, 2026
- Board approved Q2/FY26 results; auditors flagged ₹38.03 crore voucher inventory and ransomware-affected records.
-
Result- Audited Financial Result For Quarter Ended September 30,2026
- Board approved standalone results for quarter and year ended September 30, 2026; loss widened to ₹116.12 lakh.
-
Board Meeting Intimation for Prior Intimation Of Board Meeting Of The Company To Be Held On 13-11-2026.
- Board meeting on November 13, 2026 to approve Q2 FY2026 standalone unaudited results; trading window closed from October 1.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1][2][3]
FCHL is in the business of providing healthcare products and services through integrating AI technology and traditional healthcare delivery systems. It has 150 beds, 30 specialities, 300 allied staff, and 40 ICU beds. The company is working closely with Ready Technologies, a unit of Onelife Capital Advisors Ltd (a promoter group company), to develop user-friendly software/ applications which it plans to market aggressively in India and abroad.